ApprovalTrail

Drug · DIN 02515474

PONVORY

INITIATION PACK CONTAINING 14 TABLET BLISTER PACK OF DIFFERENT STRENGTHS

Authorized, but not sold for a year or more

Authorized, but the company reports it has not been sold in Canada for at least 12 months.

Status Dormant since August 27, 2025; first marketed November 1, 2021.
Drug Identification Number (DIN)
02515474
Company (DIN owner)
Vanda Pharmaceuticals Inc.Washington, District Of Columbia, United States
Schedule
Prescription
Dosage form
Tablet
Route
Oral
Therapeutic class (ATC)
Ponesimod L04AE04
Class
Human
Record last updated
September 21, 2026

Active ingredients

As listed in the Drug Product Database.

IngredientStrengthPer
PONESIMOD2 MG
PONESIMOD3 MG
PONESIMOD4 MG
PONESIMOD5 MG
PONESIMOD6 MG
PONESIMOD7 MG
PONESIMOD8 MG
PONESIMOD9 MG
PONESIMOD10 MG

Notices of Compliance

Health Canada approvals that name this DIN.

Other DINs named PONVORY